JIMT-1 breast cancer cells were pre-treated with the proposed inhibitor for 24 h, then treated with 0.3 mm GPN for 12 min to disrupt lysosomes, and then fixed and stained for galectin-3 (Fig. 5). The gene discussed is LGALS3; the disease is breast cancer.